Abstract

Streptococcus pneumoniae meningitis is a life-threatening bacterial infection of the central nervous system (CNS), and its unfavorable prognosis usually results from an intense inflammatory response. Recent studies have shown that brain-derived neurotrophic factor (BDNF) mediates anti-inflammatory and neuroprotective effects in CNS diseases; however, the distinct contribution of BDNF to pneumococcal meningitis (PM) remains unknown. In this study, we sought to investigate the effects of endogenous BDNF on the inflammatory response and brain damage in experimental PM. We used Camk2a-CreERT2 mice to delete Bdnf from the cerebral cortex and hippocampus, and meningitis was induced by intracisternal infection with S. pneumoniae. Clinical parameters were assessed during acute meningitis. At 24 h post-infection, histopathology, neutrophil granulocytes infiltration, and microglia/macrophage proliferation of brain tissues were evaluated. Additionally, cortical damage and hippocampal apoptosis were assessed using Nissl staining and terminal deoxynucleotidyl transferase dUTP-nick-end labeling (TUNEL), respectively. Pro-inflammatory cytokine levels were determined using real-time polymerase chain reaction (RT-PCR). Key molecules associated with the related signaling pathways were analyzed by RT-PCR and western blot. To investigate the role of microglia/macrophage in infected BDNF conditional knockout mice, GW2580 was used for microglia/macrophage depletion. Here, we, for the first time, found that BDNF conditional knockouts exhibited more profound clinical impairment, pathological severity, and neuron injury and enhanced microglia/macrophage proliferation than were observed in their littermate controls. Furthermore, the BDNF conditional knockouts showed an obviously increase in the expression of pro-inflammatory factors (Tnf-α, Il-1β, and Il-6). Mechanistically, loss of BDNF activated TLR2- and NOD2-mediated downstream nuclear factor kappa B (NF-κB) p65 and p38 mitogen-activated protein kinase (MAPK) pathways associated with S. pneumoniae infection. Furthermore, targeted depletion of microglia/macrophage population decreased the resistance of mice to PM with diminishing neuroinflammation in BDNF conditional knockouts. Our findings suggest that loss of BDNF may enhance the inflammatory response and contribute to brain injury during PM at least partially by modulating TLR2- and NOD2-mediated signaling pathways, thereby providing a potential therapeutic target for future interventions in bacterial meningitis pathologies.

Highlights

  • Bacterial meningitis (BM) is a serious infection of the central nervous system (CNS) characterized by inflammation of the meninges and subarachnoid space [1]

  • The results showed that there were no differences between the genotypes in the expression levels of Brain-derived neurotrophic factor (BDNF) in the brainstem (Figure S1)

  • We investigated the influence of BDNF deletion on S. pneumoniae-induced activation of Nuclear factor kappa B (NF-κB) p65 and p38 mitogen-activated protein kinases (MAPKs), which are two common downstream factors in both the Toll-like receptor 2 (TLR2) and the nucleotide-binding oligomerization domain 2 (NOD2) signaling pathway [40, 41]

Read more

Summary

Introduction

Bacterial meningitis (BM) is a serious infection of the central nervous system (CNS) characterized by inflammation of the meninges and subarachnoid space [1]. It has become evident that the development and progression of PM and the extensive tissue damage that occurs during infection are not due to the infectious agent itself but are largely dependent on the intense activation of the host immune response [6]. Bacterial lysis such as peptidoglycan, cell wall fragments generated during antibiotics treatment is highly immunogenic and may mediate neuronal cell injury and death by promoting the production of pro-inflammatory factors such as tumor necrosis factor (TNF)-α and interleukin (IL)−1β that exacerbate neurodegenerative pathology [7, 8]. Possible therapeutic approaches to block TNF-α and/or IL-1β release are investigated in animal models of BM [9, 10]

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.